Apeiron announces start of Phase I trial

Apeiron’s project APN401, based on the collection, stimulation and subsequent re-administration of a patient’s immune cells, is being investigated in a clinical Phase I trial performed at a renowned, academic medical centre in the United States.
Source: Pharmacy Europe - Category: Drugs & Pharmacology Authors: Tags: *** Editor's Pick Clinical trials Practical therapeutics Industry News Drug development Oncology Patient care Research Apeiron APN311 Latest News SIOPEN study group Source Type: news